At Darst Dermatology in Charlotte, NC we are currently recruiting individual as research participants.

Hidradenitis Suppurativa:

Chemocentryx CL016_168 - A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa.

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa

Inclusion Criteria:

• Aged at least 18 years of age;
• Clinical diagnosis of HS (Hurley Stage II or III)

For more information, visit clinicaltrials.gov

If interested in participating in a clinical trial at Darst Dermatology, email us at [email protected]